M. Ruiz

696 total citations
23 papers, 544 citations indexed

About

M. Ruiz is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, M. Ruiz has authored 23 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Infectious Diseases and 7 papers in Molecular Medicine. Recurrent topics in M. Ruiz's work include Mycobacterium research and diagnosis (14 papers), Tuberculosis Research and Epidemiology (13 papers) and Antibiotic Resistance in Bacteria (7 papers). M. Ruiz is often cited by papers focused on Mycobacterium research and diagnosis (14 papers), Tuberculosis Research and Epidemiology (13 papers) and Antibiotic Resistance in Bacteria (7 papers). M. Ruiz collaborates with scholars based in Spain, Peru and United States. M. Ruiz's co-authors include Juan Carlos Rodrı́guez, Gloria Royo, Eduardo García-Pachón, Isabel Escribano, Holger Mayta, Héctor H. Garcı́a, Juan A. Jiménez, Manuela Verástegui, Armando E. González and Robert H. Gilman and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and International Journal of Antimicrobial Agents.

In The Last Decade

M. Ruiz

23 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ruiz Spain 10 358 308 114 111 90 23 544
C A Sanders United States 18 567 1.6× 551 1.8× 183 1.6× 108 1.0× 59 0.7× 24 819
Lúcia Helena Vitali Brazil 8 154 0.4× 180 0.6× 15 0.1× 59 0.5× 113 1.3× 14 396
Alessandra Bua Italy 16 544 1.5× 477 1.5× 182 1.6× 164 1.5× 61 0.7× 32 741
Alex G. Peniche United States 16 131 0.4× 156 0.5× 73 0.6× 181 1.6× 14 0.2× 21 543
Samin Zamani Iran 13 281 0.8× 268 0.9× 139 1.2× 185 1.7× 54 0.6× 25 517
İştar Dolapçı Türkiye 11 135 0.4× 86 0.3× 55 0.5× 75 0.7× 79 0.9× 46 335
Marcia L. Sokol-Anderson United States 9 250 0.7× 186 0.6× 21 0.2× 83 0.7× 8 0.1× 12 425
Samudi Chandramathi Malaysia 13 228 0.6× 52 0.2× 44 0.4× 80 0.7× 19 0.2× 19 499
Ilana Teruszkin Balassiano Brazil 16 260 0.7× 136 0.4× 33 0.3× 104 0.9× 8 0.1× 32 602
Angelika Jellen-Ritter Germany 11 60 0.2× 99 0.3× 17 0.1× 289 2.6× 363 4.0× 11 710

Countries citing papers authored by M. Ruiz

Since Specialization
Citations

This map shows the geographic impact of M. Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ruiz more than expected).

Fields of papers citing papers by M. Ruiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ruiz. The network helps show where M. Ruiz may publish in the future.

Co-authorship network of co-authors of M. Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ruiz. A scholar is included among the top collaborators of M. Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ruiz. M. Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martí, María José, et al.. (2023). Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease. PLoS ONE. 18(9). e0282814–e0282814. 10 indexed citations
2.
Rodrı́guez, Juan Carlos, et al.. (2010). Activity of various drugs alone or in combination against Mycobacterium fortuitum. Journal of Infection and Chemotherapy. 16(1). 64–67. 1 indexed citations
3.
Cremades, Rosa, Juan Carlos Rodrı́guez, Eduardo García-Pachón, et al.. (2009). Screening for Sterilizing Activity of Antibiotic Combinations in an Acid Model of Rapidly Growing Mycobacteria during the Stationary Phase of Growth. Chemotherapy. 55(2). 114–118. 9 indexed citations
4.
Rodríguez‐Rey, José C., et al.. (2008). Generación in vitro de mutantes de Klebsiella pneumoniae tras la exposición a fluoroquinolonas. Relación con la presencia de betalactamasas de espectro extentido. Revista española de quimioterapia. Suplemento. 21(3). 180–183. 2 indexed citations
5.
Cremades, Rosa, et al.. (2008). In VitroBactericidal Activity of Antibiotic Combinations Against Clinical Isolates ofMycobacterium chelonae. Journal of Chemotherapy. 20(1). 43–47. 8 indexed citations
6.
Escribano, Isabel, et al.. (2007). Importance of the Efflux Pump Systems in the Resistance of <i>Mycobacterium tuberculosis</i> to Fluoroquinolones and Linezolid. Chemotherapy. 53(6). 397–401. 103 indexed citations
7.
García-Pachón, Eduardo, Isabel Escribano, Juan Carlos Rodrı́guez, et al.. (2007). Incidence of Beijing genotype of Mycobacterium tuberculosis in Elche, Spain: A 13-year surveillance study. Eurosurveillance. 12(5). 17–18. 6 indexed citations
8.
Pérez, José Carlos Rodríguez, et al.. (2006). Evaluación de un método rápido para la detección de betalactamasas de espectro extendido mediante una cefalosporina cromogénica. Acceda (Universidad de Las Palmas de Gran Canaria). 19(2). 185–186. 1 indexed citations
9.
Cebrián, Laura, et al.. (2006). Disminución de la actividad bactericida del ciprofloxacino en mutantes de Salmonella generados tras exposición repetida a diversas fluoroquinolonas. Hispana. 19(4). 363–366. 1 indexed citations
10.
Rodrı́guez, Juan Carlos, Eduardo García-Pachón, M. Ruiz, & Gloria Royo. (2006). Drug Susceptibility of the Mycobacterium Genus: In Vitro Tests and Clinical Implications. Current Clinical Pharmacology. 1(3). 277–289. 5 indexed citations
11.
Rodrı́guez, Juan Carlos, et al.. (2005). Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration. International Journal of Antimicrobial Agents. 25(3). 221–225. 9 indexed citations
12.
Rodrı́guez, Juan Carlos, et al.. (2005). Mutant Prevention Concentration of Isoniazid, Rifampicin and Rifabutin against <i>Mycobacterium tuberculosis</i>. Chemotherapy. 51(2-3). 76–79. 3 indexed citations
13.
Rodrı́guez, Juan Carlos, et al.. (2004). Action of Fluoroquinolones and Linezolid on Logarithmic- and Stationary-Phase Culture of <i>Mycobacterium tuberculosis</i>. Chemotherapy. 50(5). 211–213. 17 indexed citations
14.
Ruiz, M., et al.. (2003). Effect of clinical and socio-economic factors on the rate of clustering of Mycobacterium tuberculosis clinical isolates in Elche (Spain). Epidemiology and Infection. 131(3). 1077–1083. 5 indexed citations
15.
Ruiz, M., et al.. (2003). Usefulness of different techniques in the study of the epidemiology of salmonellosis. Apmis. 111(9). 848–856. 10 indexed citations
16.
Rodrı́guez, Juan Carlos, et al.. (2003). Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis. International Journal of Antimicrobial Agents. 21(4). 354–356. 27 indexed citations
17.
Rodrı́guez, Juan Carlos, et al.. (2002). In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. International Journal of Antimicrobial Agents. 20(6). 464–467. 123 indexed citations
18.
Rodrı́guez, Juan Carlos, et al.. (2000). [Eye foreign object].. PubMed. 18(2). 87–8. 1 indexed citations
19.
Mayta, Holger, Robert H. Gilman, Juan A. Jiménez, et al.. (2000). Differentiating Taenia solium and Taenia saginata Infections by Simple Hematoxylin-Eosin Staining and PCR-Restriction Enzyme Analysis. Journal of Clinical Microbiology. 38(1). 133–137. 88 indexed citations
20.
Ruiz, M., et al.. (1999). [Evolution of resistance to quinolones in Salmonella enterica in our setting].. PubMed. 12(4). 366–368. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Sanders Breakdown of academic impact, for papers by Lúcia Helena Vitali Breakdown of academic impact, for papers by Alessandra Bua Breakdown of academic impact, for papers by Alex G. Peniche Breakdown of academic impact, for papers by Samin Zamani Breakdown of academic impact, for papers by İştar Dolapçı Breakdown of academic impact, for papers by Marcia L. Sokol-Anderson Breakdown of academic impact, for papers by Samudi Chandramathi Breakdown of academic impact, for papers by Ilana Teruszkin Balassiano Breakdown of academic impact, for papers by Angelika Jellen-Ritter
Rankless by CCL
2026